Divergent Effects of miR‐181 Family Members on Myocardial Function Through Protective Cytosolic and Detrimental Mitochondrial microRNA Targets

Background MicroRNA (miRNA) is a type of noncoding RNA that can repress the expression of target genes through posttranscriptional regulation. In addition to numerous physiologic roles for miRNAs, they play an important role in pathophysiologic processes affecting cardiovascular health. Previously, we reported that nuclear encoded microRNA (miR‐181c) is present in heart mitochondria, and importantly, its overexpression affects mitochondrial function by regulating mitochondrial gene expression. Methods and Results To investigate further how the miR‐181 family affects the heart, we suppressed miR‐181 using a miR‐181‐sponge containing 10 repeated complementary miR‐181 “seed” sequences and generated a set of H9c2 cells, a cell line derived from rat myoblast, by stably expressing either a scrambled or miR‐181‐sponge sequence. Sponge‐H9c2 cells showed a decrease in reactive oxygen species production and reduced basal mitochondrial respiration and protection against doxorubicin‐induced oxidative stress. We also found that miR‐181a/b targets phosphatase and tensin homolog (PTEN), and the sponge‐expressing stable cells had increased PTEN activity and decreased PI3K signaling. In addition, we have used miR‐181a/b−/− and miR‐181c/d−/− knockout mice and subjected them to ischemia‐reperfusion injury. Our results suggest divergent effects of different miR‐181 family members: miR‐181a/b targets PTEN in the cytosol, resulting in an increase in infarct size in miR‐181a/b−/− mice due to increased PTEN signaling, whereas miR‐181c targets mt‐COX1 in the mitochondria, resulting in decreased infarct size in miR‐181c/d−/− mice. Conclusions The miR‐181 family alters the myocardial response to oxidative stress, notably with detrimental effects by targeting mt‐COX1 (miR‐181c) or with protection by targeting PTEN (miR‐181a/b).

[1]  M. Aon,et al.  ErbB2 overexpression upregulates antioxidant enzymes, reduces basal levels of reactive oxygen species, and protects against doxorubicin cardiotoxicity. , 2015, American journal of physiology. Heart and circulatory physiology.

[2]  Yi Zhang,et al.  MicroRNA Directly Enhances Mitochondrial Translation during Muscle Differentiation , 2014, Cell.

[3]  A. Maitra,et al.  miR-181c Regulates the Mitochondrial Genome, Bioenergetics, and Propensity for Heart Failure In Vivo , 2014, PloS one.

[4]  R. Bak,et al.  Managing microRNAs with vector-encoded decoy-type inhibitors. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[5]  Adam Williams,et al.  The microRNA miR-181 is a critical cellular metabolic rheostat essential for NKT cell ontogenesis and lymphocyte development and homeostasis. , 2013, Immunity.

[6]  D. Tomar,et al.  Systematic Analysis of Small RNAs Associated with Human Mitochondria by Deep Sequencing: Detailed Analysis of Mitochondrial Associated miRNA , 2012, PloS one.

[7]  Sarah B. Scruggs,et al.  An MRM-based workflow for quantifying cardiac mitochondrial protein phosphorylation in murine and human tissue. , 2012, Journal of Proteomics.

[8]  Sarah J. Wheelan,et al.  Nuclear miRNA Regulates the Mitochondrial Genome in the Heart , 2012, Circulation research.

[9]  M. Latronico,et al.  The might of microRNA in mitochondria. , 2012, Circulation Research.

[10]  G. Dorn,et al.  A Human 3′ miR-499 Mutation Alters Cardiac mRNA Targeting and Function , 2012, Circulation research.

[11]  Stefan L Ameres,et al.  Long-term, efficient inhibition of microRNA function in mice using rAAV vectors , 2012, Nature Methods.

[12]  C. Steenbergen,et al.  Mitochondrial adenine nucleotide transport and cardioprotection. , 2012, Journal of molecular and cellular cardiology.

[13]  Arnold Munnich,et al.  Nuclear Outsourcing of RNA Interference Components to Human Mitochondria , 2011, PloS one.

[14]  X. Gidrol,et al.  Pre-microRNA and Mature microRNA in Human Mitochondria , 2011, PloS one.

[15]  J. Stenvang,et al.  Silencing of microRNA families by seed-targeting tiny LNAs , 2011, Nature Genetics.

[16]  John J Rossi,et al.  Stopping RNA interference at the seed , 2011, Nature Genetics.

[17]  Phillip A Sharp,et al.  MicroRNA sponges: progress and possibilities. , 2010, RNA.

[18]  X. Chen,et al.  Identification of mouse liver mitochondria-associated miRNAs and their potential biological functions , 2010, Cell Research.

[19]  Dong I. Lee,et al.  PDE5A suppression of acute β-adrenergic activation requires modulation of myocyte beta-3 signaling coupled to PKG-mediated troponin I phosphorylation , 2010, Basic Research in Cardiology.

[20]  D. V. Vactor,et al.  NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript NIH Public Access Author Manuscript Nat Methods. Author manuscript; available in PMC 2011 September 30. , 2009 .

[21]  James D Yager,et al.  Regulation of mitochondrial respiratory chain biogenesis by estrogens/estrogen receptors and physiological, pathological and pharmacological implications. , 2009, Biochimica et biophysica acta.

[22]  X. Wang,et al.  Identification of microRNA‐181 by genome‐wide screening as a critical player in EpCAM–positive hepatic cancer stem cells , 2009, Hepatology.

[23]  C. Croce,et al.  Unique MicroRNA Profile in End-stage Heart Failure Indicates Alterations in Specific Cardiovascular Signaling Networks* , 2009, The Journal of Biological Chemistry.

[24]  E. Murphy,et al.  Cardioprotection and altered mitochondrial adenine nucleotide transport , 2009, Basic Research in Cardiology.

[25]  C. Steer,et al.  MicroRNAs identified in highly purified liver-derived mitochondria may play a role in apoptosis , 2009, RNA biology.

[26]  E. Murphy,et al.  Glycogen Synthase Kinase 3 Inhibition Slows Mitochondrial Adenine Nucleotide Transport and Regulates Voltage-Dependent Anion Channel Phosphorylation , 2008, Circulation Research.

[27]  E. Olson,et al.  Toward microRNA-based therapeutics for heart disease: the sense in antisense. , 2008, Circulation research.

[28]  E. Murphy,et al.  Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. , 2008, Physiological reviews.

[29]  Margaret S. Ebert,et al.  MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells , 2007, Nature Methods.

[30]  E. Murphy,et al.  Preconditioning: the mitochondrial connection. , 2007, Annual review of physiology.

[31]  Eduardo Ruiz-Pesini,et al.  Mitochondrial DNA transcription and diseases: past, present and future. , 2006, Biochimica et biophysica acta.

[32]  M. Dietel,et al.  The PI3K inhibitor LY294002 blocks drug export from resistant colon carcinoma cells overexpressing MRP1 , 2006, Oncogene.

[33]  V. Ambros The functions of animal microRNAs , 2004, Nature.

[34]  D. Bers,et al.  Na-Ca exchange is required for rest-decay but not for rest-potentiation of twitches in rabbit and rat ventricular myocytes. , 1994, Journal of molecular and cellular cardiology.